InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by David Kirn. Officer active across 1 company, notably 4D Molecular Therapeutics, Inc.. Cumulatively, 7 disclosures have been logged. Activity tracked since 22 June 2026. The latest transaction was disclosed on 14 September 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
David Kirn is an officer of 4D Molecular Therapeutics, Inc. (XNAS). He has 6 filings in total, and across the 6 recent sampled filings they are all sales, for a total of EUR 3043485, with filings dated from 2026-06-22 to 2026-08-19; the most frequent transaction nature is Notice of proposed sale (Form 144).